Lung cancer is a prominent malignancy posing a significant threat to individuals in China and other nations alike¹. Timely diagnosis plays a pivotal role in achieving the most favorable prognosis. The detection of lung nodules presents challenges due to their diverse characteristics in terms of size, location, and appearance². Moreover, the identification of numerous false positive nodules remains an urgent issue that needs resolution during clinical CT examinations and LDCT screenings. Excessive false positives can result in overdiagnosis, overtreatment, wastage of medical resources, and heightened patient anxiety³.

The objective of BINARY is to expedite the diagnostic process for patients by facilitating access to hard-to-reach nodules within the surrounding lung tissue for biopsy purposes. BINARY aims to assist both patients and physicians in obtaining prompt results along the pathway towards diagnosing lung nodules.